Hideko Goto

541 total citations
29 papers, 408 citations indexed

About

Hideko Goto is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Hideko Goto has authored 29 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 11 papers in Oncology and 8 papers in Genetics. Recurrent topics in Hideko Goto's work include Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (7 papers) and CNS Lymphoma Diagnosis and Treatment (7 papers). Hideko Goto is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (7 papers) and CNS Lymphoma Diagnosis and Treatment (7 papers). Hideko Goto collaborates with scholars based in Japan. Hideko Goto's co-authors include Hisashi Tsurumi, Hisataka Moriwaki, Senji Kasahara, Kenji Fukuno, Takeshi Hara, Michio Sawada, Toshiki Yamada, Tsuyoshi Takami, Naoe Goto and Shinobu Tanabashi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Chromatography A.

In The Last Decade

Hideko Goto

27 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideko Goto Japan	13	211	117	91	91	69	29	408
Ivo Radman Croatia	12	154 0.7×	145 1.2×	119 1.3×	44 0.5×	33 0.5×	44	417
Lynny Yung United Kingdom	5	227 1.1×	184 1.6×	55 0.6×	60 0.7×	65 0.9×	7	315
Naoto Fujita Japan	12	189 0.9×	136 1.2×	56 0.6×	47 0.5×	74 1.1×	42	392
F Parmentier France	13	259 1.2×	159 1.4×	171 1.9×	63 0.7×	22 0.3×	15	449
C. Zwick Germany	8	102 0.5×	128 1.1×	51 0.6×	119 1.3×	48 0.7×	9	401
Kouichi Ohshima Japan	11	189 0.9×	126 1.1×	68 0.7×	115 1.3×	73 1.1×	33	403
Luisa Tavecchia Italy	10	111 0.5×	85 0.7×	124 1.4×	110 1.2×	23 0.3×	12	390
Robert Peter Gale United States	7	141 0.7×	168 1.4×	69 0.8×	42 0.5×	76 1.1×	12	395
Xavier Cahu France	12	109 0.5×	146 1.2×	114 1.3×	80 0.9×	26 0.4×	22	414
Brian D. Kueck United States	9	137 0.6×	82 0.7×	113 1.2×	80 0.9×	40 0.6×	14	298

Countries citing papers authored by Hideko Goto

Since Specialization

Citations

This map shows the geographic impact of Hideko Goto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideko Goto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideko Goto more than expected).

Fields of papers citing papers by Hideko Goto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideko Goto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideko Goto. The network helps show where Hideko Goto may publish in the future.

Co-authorship network of co-authors of Hideko Goto

This figure shows the co-authorship network connecting the top 25 collaborators of Hideko Goto. A scholar is included among the top collaborators of Hideko Goto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideko Goto. Hideko Goto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamada, Toshiki, Nobuhiko Nakamura, Hideko Goto, et al.. (2025). Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study. Annals of Hematology. 104(10). 5191–5200. 1 indexed citations

Nakamura, Nobuhiko, Nobuhiro Kanemura, Takuro Matsumoto, et al.. (2023). Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population. Scientific Reports. 13(1). 19060–19060. 2 indexed citations

Kawakami, Hideaki, Kiyofumi Mochizuki, Hideko Goto, Naoki Watanabe, & Takuji Tanaka. (2017). Orbital T-Cell Lymphoma with Discrete Enlargements of All Extraocular Muscles Bilaterally in Patient with Moon Face Countenance. SHILAP Revista de lepidopterología. 2017. 1–5. 2 indexed citations

Tanaka, Osamu, et al.. (2016). Low dose palliative radiotherapy for refractory aggressive lymphoma. Reports of Practical Oncology & Radiotherapy. 21(6). 495–499. 10 indexed citations

Takahashi, Takeshi, Masahiro Yasuda, Tomoya Tachi, et al.. (2015). [A female chronic myeloid leukemia patient who gave birth after stopping imatinib intentionally but who maintained a major molecular response with interferon].. PubMed. 42(4). 477–9. 1 indexed citations

Yasuda, Masahiro, et al.. (2014). [Analysis of factors influencing the occurrence of infusion reaction after initial treatment with rituximab].. PubMed. 41(8). 975–9.

Kasahara, Senji, Takeshi Hara, Hisashi Tsurumi, et al.. (2011). Phase II study of the tetrahydropyranyl adriamycin–cyclophosphamide, vincristine, and prednisolone regimen combined with rituximab as first-line treatment for elderly patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 52(4). 629–634. 22 indexed citations

Tsurumi, Hisashi, Takeshi Hara, Naoe Goto, et al.. (2011). A phase II study of rituximab combined with pirarubicin–cyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma. Leukemia & lymphoma. 53(2). 247–253. 2 indexed citations

Goto, Naoe, Hisashi Tsurumi, Hideko Goto, et al.. (2011). Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens. Annals of Hematology. 91(5). 705–714. 51 indexed citations

10.

Hara, Takeshi, Hisashi Tsurumi, Naoe Goto, et al.. (2009). Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP. Journal of Cancer Research and Clinical Oncology. 135(10). 1421–1428. 12 indexed citations

11.

Hara, Takeshi, Hisashi Tsurumi, Naoe Goto, et al.. (2009). Phase II study of Rituximab combined with THP-COP as first-line therapy for patients younger than 70 years with diffuse large B cell lymphoma. Journal of Cancer Research and Clinical Oncology. 136(1). 65–70. 17 indexed citations

12.

Goto, Hideko, Takeshi Hara, Hisashi Tsurumi, Shinobu Tanabashi, & Hisataka Moriwaki. (2009). Chronic Neutrophilic Leukemia with Congenital Robertsonian Translocation Successfully Treated with Allogeneic Bone Marrow Transplantation in a Young Man. Internal Medicine. 48(7). 563–567. 17 indexed citations

13.

Fukuno, Kenji, Hisashi Tsurumi, Nobuhiro Ando, et al.. (2006). Late-Onset Neutropenia in Patients Treated with Rituximab for Non-Hodgkin's Lymphoma. International Journal of Hematology. 84(3). 242–247. 27 indexed citations

14.

Kato, Tatsuo, et al.. (2005). [A case of lung adenocarcinoma of the lung with disappearance of brain metastasis by re-treatment with gefitinib].. PubMed. 43(11). 700–3. 2 indexed citations

15.

Goto, Hideko, Hisashi Tsurumi, Masao Takemura, et al.. (2004). Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin?s lymphoma: in combination with the International Prognostic Index. Journal of Cancer Research and Clinical Oncology. 131(2). 73–79. 57 indexed citations

16.

Fukuno, Kenji, et al.. (2003). Genital Ulcers During Treatment with ALL-transRetinoic Acid for Acute Promyelocytic Leukemia. Leukemia & lymphoma. 44(11). 2009–2013. 17 indexed citations

17.

Sawada, Michio, Hisashi Tsurumi, Toshiki Yamada, et al.. (2002). A prospective study of P‐IMVP‐16/CBDCA: a novel salvage chemotherapy for patients with aggressive non‐Hodgkin's lymphoma who had previously received CHOP therapy as first‐line chemotherapy. European Journal Of Haematology. 68(6). 354–361. 28 indexed citations

18.

Kasahara, Senji, Hisashi Tsurumi, Takeshi Hara, Hideko Goto, & Hisataka Moriwaki. (2000). Idiopathic Myelofibrosis Developing Isolated Granulocytic Sarcoma with der (1;7)(q10; p10) After Splenectomy and Finally Transforming to Acute Myelogenous Leukemia. Leukemia & lymphoma. 39(3-4). 427–433. 16 indexed citations

19.

Hara, Takeshi, Hisashi Tsurumi, Masao Takemura, et al.. (2000). Serum-soluble Fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma. American Journal of Hematology. 64(4). 257–261. 39 indexed citations

20.

Goto, Hideko, et al.. (1999). A Case of Triple Cancer with Hypercalcemia Due to PTHrP.. Haigan. 39(6). 863–869. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact